Dartmouth Cancer Center names internationally renowned cancer research pioneer Roy Herbst, MD, Ph.D., as its next leader
Business Announcement
Updates every hour. Last Updated: 22-Jun-2026 12:16 ET (22-Jun-2026 16:16 GMT/UTC)
Researchers from the University of Missouri School of Medicine may have found a way to identify the patients at risk of recurrence for follicular lymphoma cancer without the need for imaging and surveillance testing by screening patients for several diffferent biomarkers.
The Keck School of Medicine of USC and the USC Viterbi School of Engineering have announced that the Alfred E. Mann Department of Biomedical Engineering will become a joint department between the two schools, forging a formal partnership in education, research and innovation in technology and medicine. This joint department, one of the first of its kind in California, builds on decades of cross-disciplinary research and breakthroughs at USC, including the world’s first FDA-approved artificial retina, the first brain implant to restore lost memory function, and innovations in immunotherapy to treat cancer. With added support from USC’s president and provost, the newly integrated biomedical engineering department will create new structures and gain new resources dedicated to further accelerating biomedical innovation, enriching educational programs and advancing technology in medicine. It will combine expertise in priority areas spanning medical devices, neuroengineering, imaging science, drug discovery, artificial intelligence (AI) and informatics, cellular and molecular bioengineering, and more. Facilities at both the Viterbi School of Engineering and the Keck School of Medicine will be devoted to the joint department, with the chair reporting to both deans. Yingxiao (Peter) Wang, PhD, the department’s current chair, who also holds the Dwight C. and Hildagarde E. Baum Chair in Biomedical Engineering, will help implement the transition by leading the department into its next phase.
When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs. A new study led by reserachers at the Brown University School of Public Health shows that some of those abnormalities could be signs of other undiagnosed cancers.
The San Antonio Breast Cancer Symposium® drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio.